Share on LinkedInShare on LinkedIn

ARTICLE · 01 DECEMBER 2016

Canada And CETA: Changes To Patent Term Restoration, PM(NOC) Decisions Appeals And Dual Litigation

Torys
Torys
Contributor
Torys

Torys

Torys LLP is an international business law firm that works with clients who expect the best advice...

View firm profile
Explore more from Torys

On October 30, Canada signed the Comprehensive Economic and Trade Agreement (CETA) at the European Union-Canada Leaders' Summit.

CanadaIntellectual Property

On October 30, Canada signed the Comprehensive Economic and Trade Agreement (CETA) at the European Union-Canada Leaders' Summit. The following day, Bill C-30, An Act to implement the Comprehensive Economic and Trade Agreement between Canada and the European Union and its Member States and to provide for certain other measures, was introduced in the House of Commons.1

Bill C-30 proposes amendments to a number of Canadian statutes to bring them into conformity with Canada's obligations under CETA. This bulletin highlights the amendments relating to patent law that deal with patent term restoration for pharmaceuticals, appeals under the Patented Medicines (Notice of Compliance) (PM(NOC)) Regulations and dual litigation.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from